[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Webmail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 20, Issue 1 (spring 2010) ::
MEDICAL SCIENCES 2010, 20(1): 22-27 Back to browse issues page
Role of ATP-sensitive potassium channels in the clonic seizure threshold inuced by pentylenetetrazole in mice with diabetes type I
Hamed Shafaroodi 1, Mehrdad Hashemi , Ahmad Reza Dehpour
Abstract:   (21780 Views)
Background: Although there is evidence that diabetes affects seizure susceptibility, the underlying mechanism has not been completely understood. On the other hand, several studies have suggested a pivotal role for KATP channels in the seizure modulation. So, the present study was designed to evaluate the seizure threshold induced by pentylenetetrazole (PTZ) in diabetic mice at different times and to examine the possible role of ATP-sensitive potassium (KATP) channels.
Materials and methods: In this experimental study, NMRI were diabetic with streptozocine. Then clonic seizure thresholds were determined at different times after induction of diabetes compared with corresponding non-diabetic groups. Each experimental group consisted of ten mice.
Results: There was a time-dependent alteration in the threshold in diabetic mice, reaching a peak on week 2 after STZ injection and declining significantly afterwards. The seizure threshold in 8-week diabetic mice was even lower than control levels, though the difference was not significant. The non-effective dose of KATP channel blocker glibenclamide (1 mg/kg,i.p.), but not the voltage-dependent K+ channel blocker 4-aminopyridine (1 mg/kg,i.p.), decreased the seizure threshold in 2-week diabetic mice to the control levels which was blocked by pre-treatment with the KATP channel opener cromakalim (10 μg/kg,i.p.). Moreover, the non-effective dose of cromakalim (10 μg/kg,i.p.) increased significantly the seizure threshold in 8-week diabetic mice which was inhibited by pre-treatment with glibenclamide (1 mg/kg,i.p.) but not with 4-aminopyridine (1 mg/kg,i.p.).
 Conclusion: This study indicated that the PTZ-induced seizure threshold is altered in diabetic mice in a time-dependent manner which could be due to the probable alteration in the KATP channel functioning during diabetes.
Keywords: Diabetes, Clonic seizure threshold, ATP-sensitive potassium (KATP) channel, Glibenclamide, Cromakalim, Mice
Full-Text [PDF 1032 kb]   (3562 Downloads)    
Subject: Epidemiology
Received: 2010/08/19 | Published: 2010/04/15
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shafaroodi H, Hashemi M, Dehpour A R. Role of ATP-sensitive potassium channels in the clonic seizure threshold inuced by pentylenetetrazole in mice with diabetes type I. MEDICAL SCIENCES 2010; 20 (1) :22-27
URL: http://tmuj.iautmu.ac.ir/article-1-279-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 20, Issue 1 (spring 2010) Back to browse issues page
فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645